Nuciferine alleviates collagen-induced arthritic in rats by inhibiting the proliferation and invasion of human arthritis-derived fibroblast-like synoviocytes and rectifying Th17/Treg imbalance

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disorder marked by persistent synovial inflammation and joint degradation, posing challenges in the development of effective treatments. Nuciferine, an alkaloid found in lotus leaf, has shown promising anti-inflammatory and anti-tumor effects, yet its efficacy in RA treatment remains unexplored. This study investigated the antiproliferative effects of nuciferine on the MH7A cell line, a human RA-derived fibroblast-like synoviocyte, revealing its ability to inhibit cell proliferation, promote apoptosis, induce apoptosis, and cause G₁/S phase arrest. Additionally, nuciferine significantly reduced the migration and invasion capabilities of MH7A cells. The therapeutic potential of nuciferine was further evaluated in a collagen-induced arthritis (CIA) rat model, where it markedly alleviated joint swelling, synovial hyperplasia, cartilage injury, and inflammatory infiltration. Nuciferine also improved collagen-induced bone erosion, decreased pro-inflammatory cytokines and serum immunoglobulins (IgG, IgG1, IgG2a), and restored the balance between T helper (Th) 17 and regulatory T cells in the spleen of CIA rats. These results indicate that nuciferine may offer therapeutic advantages for RA by decreasing the proliferation and invasiveness of FLS cells and correcting the Th17/Treg cell imbalance in CIA rats.

Keywords

Rheumatoid arthritis / Collagen-induced arthritis / Fibroblast-like synoviocyte / Immune imbalance / Nuciferine341-355/img_1.wmf72.018.25

References

[1] Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis[J]. Lancet, 2010, 376: 1094-1108.

[2] Smolen JS, Aletaha DI, McInnes B, Rheumatoid arthritis[J]. Lancet, 2016. 388, 2023-2038.

[3] Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis[J]. Autoimmun, 2020, 110: 102400.

[4] Tu J, Hong W, Zhang P, et al. Ontology and function of fibroblast-like and macrophage-like synoviocytes: how do they talk to each other and can they be targeted for rheumatoid arthritis therapy[J]. Front Immunol, 9, 1467.

[5] You S, Koh JH, Leng L, et al. The tumor-like phenotype of rheumatoid synovium: molecular profiling and prospects for precision medicine[J]. Arthritis Rheumatol, 2018, 70: 637-652.

[6] Malemud CJ, Matrix metalloproteinases and synovial joint pathology[J]. Prog Mol Biol Transl Sci, 2017, 148, 305-325.

[7] Xue M, McKelvey K, Shen K, et al. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation[J]. Rheumatology (Oxford), 2014, 53: 2270-2279.

[8] McInnes IB, Schett G. Schett, The pathogenesis of rheumatoid arthritis[J]. N Engl J Med, 2011, 365: 2205-2219.

[9] Shen P, Jiao Y, Miao L, et al. Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management[J]. J Cell Mol Med, 2020, 24: 12234-12245.

[10] Weyand CM, Goronzy JJ. Goronzy, Immunometabolism in the development of rheumatoid arthritis[J]. Immunol Rev, 2020, 294: 177-187.

[11] Shi C, Zhang H, Wang X, et al. Cinnamtannin D1 attenuates autoimmune arthritis by regulating the balance of Th17 and treg cells through inhibition of aryl hydrocarbon receptor expression[J]. Pharmacol Res, 2020, 151: 104513.

[12] Jin S, Chen H, Li Y, et al. Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21[J]. Ann. Rheum Dis, 2018, 77: 1644-1652.

[13] Batko B, Batko K, Krzanowski M, et al. Physician adherence to treat-to-target and practice guidelines in rheumatoid arthritis[J]. J Clin Med, 2019, 8: 1416.

[14] Baschant U, Lane NE, Tuckermann J, et al. The multiple facets of glucocorticoid action in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2012, 8: 645-655.

[15] Sharma BR, Gautam LNS, Adhikari D, et al. A Comprehensive Review on Chemical Profiling of Nelumbo Nucifera: Potential for Drug Development[J]. Phytother Res, 2017, 31(1): 3-26.

[16] Zhang C, Deng J, Liu D, et al. Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway[J]. Br J Pharmacol, 2018, 175(21): 4218-4228.

[17] Li Z, Chen Y, An T, et al. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway[J]. J Exp Clin Cancer Res, 2019, 38(1): 139.

[18] Nguyen KH, Ta TN, Pham TH, et al. Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide[J]. J Ethnopharmacol, 2012, 142(2): 488-495.

[19] Wang MX, Zhao XJ, Chen TY, et al. Nuciferine alleviates renal injury by inhibiting inflammatory responses in fructose-fed rats[J]. J Agric Food Chem, 2016, 64(40): 7899-7910.

[20] Song C, Cao J, Lei Y, et al. Nuciferine prevents bone loss by disrupting multinucleated osteoclast formation and promoting type H vessel formation[J]. FASEB J, 2020, 34(4): 4798-4811.

[21] Wang T, Li J, Jin Z, et al. Dynamic Frequency of Blood CD4 + CD25 + Regulatory T Cells in Rats with Collagen-induced Arthritis[J]. Korean J Physiol Pharmacol, 2015, 19(1): 83-8.

[22] Chang Y, Wu Y, Wang D, et al. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses[J]. Rheumatology (Oxford), 2011, 50(5): 862-870.

[23] Chen R, Xie P, Gu M, et al. Long noncoding RNA LBC inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2[J]. Clin Cancer Res, 2019, 25(5): 1389-1403.

[24] Du F, Lü LJ, Fu Q, et al. T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis[J]. Arthritis Res Ther, 2008, 10(6): R136.

[25] Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes[J]. Nat Rev Rheumatol, 2020, 16(6): 333-348.

[26] Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors[J]. Nat Rev Rheumatol, 2013, 9(1): 24-33.

[27] Yates M, MacGregor AJ, Ledingham J, et al. Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study[J]. Rheumatology (Oxford), 2020, 59(8): 2035-2042.

[28] Chinese Rheumatology Association. [ 2018 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis]. Zhonghua Nei Ke Za Zhi, 2018, 57(4): 242-251. Chinese.

[29] Liu W, Yi DD, Guo JL, et al. Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer[J]. J Ethnopharmacol, 2015, 165: 83-93.

[30] Pap T, Müller-Ladner U, Gay RE, et al. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis[J]. Arthritis Res, 2000, 2(5): 361-367.

[31] Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms[J]. Oncogene, 2009, 28(33): 2925-2939.

[32] Wiman KG, Zhivotovsky B. Understanding cell cycle and cell death regulation provides novel weapons against human diseases[J]. J Intern Med, 2017, 281: 483-495.

[33] Massagué J. G1 cell-cycle control and cancer[J]. Nature, 2004, 432(7015): 298-306.

[34] Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases[J]. Nat Rev Mol Cell Biol, 2013, 14(8): 518-528.

[35] Tateiwa D, Yoshikawa H, Kaito T. Cartilage and bone destruction in arthritis: pathogenesis and treatment strategy: a literature review[J]. Cells, 2019, 8: 818.

[36] Nagata S. Apoptosis and Clearance of Apoptotic Cells[J]. Annu Rev Cell Dev Biol, 2018, 36: 489-517.

[37] Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase activation during apoptosis[J]. Annu Rev Cell Dev Biol, 1999, 15: 269-290.

[38] Ma JD, Jing J, Wang JW, et al. A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients[J]. Arthritis Res Ther, 2019, 21: 153.

[39] Korb-Pap A, Bertrand J, Sherwood J, et al. Stable activation of fibroblasts in rheumatic arthritis-causes and consequences[J]. Rheumatology (Oxford), 2016, 55: ii64-ii67.

[40] Falconer J, Murphy AN, Young SP, et al. Synovial cell metabolism and chronic inflammation in rheumatoid arthritis[J]. Arthritis Rheumatol, 2018, 70: 984-999.

[41] Zhang Q, Peng W, Wei S, et al. Guizhi-Shaoyao-Zhimu decoction possesses anti-arthritic effects on type II collagen-induced arthritis in rats via suppression of inflammatory reactions, inhibition of invasion & migration and induction of apoptosis in synovial fibroblasts[J]. Biomed Pharmacother, 2019, 118: 109367.

[42] Tolboom TC, Pieterman E, van der Laan WH, et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10[J]. Ann Rheum Dis, 2002, 61: 975-980.

[43] Weyand CM, Goronzy JJ. Immunometabolism in early and late stages of rheumatoid arthritis[J]. Nat Rev Rheumatol, 2017, 13: 291-301.

[44] Pap T, Meinecke I, Müller-Ladner U. Are fibroblasts involved in joint destruction[J]. Ann Rheum Dis, 2005, 64: iv52-iv54.

[45] Du T, Yan Z, Zhu S, et al. QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism[J]. Cell Death Dis, 2020, 11(4): 330.

[46] Chen X, Zheng X, Zhang M, et al. Nuciferine alleviates LPS-induced mastitis in mice via suppressing the TLR4-NF-κB signaling pathway[J]. Inflamm Res, 2018, 67: 903-911.

[47] McNamee K, Williams R, Seed M. Animal models of rheumatoid arthritis: How informative are they[J]. Eur J Pharmacol, 2015, 759: 278-286.

[48] Chen Z, Bozec A, Ramming A, et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis[J]. Nat Rev Rheumatol, 2019, 15: 9-17.

[49] Li XF, Sun YY, Bao J, et al. Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis[J]. Sci Rep, 2017, 7: 12671.

[50] Kim EY, Moudgil KD. Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines[J]. Cytokine, 2017, 98: 87-96.

[51] Roberts CA, Dickinson AK, Taams LS. The Interplay Between Monocytes/Macrophages and CD4( + ) T Cell Subsets in Rheumatoid Arthritis[J]. Front Immunol, 2015, 6: 571.

[52] Takeuchi Y, Hirota K, Sakaguchi S. Impaired T cell receptor signaling and development of T cell-mediated autoimmune arthritis[J]. Immunol Rev, 2020, 294: 164-176.

[53] Yang Y, Zhang X, Xu M, et al. Quercetin attenuates collagen-induced arthritis by restoration of Th17/Treg balance and activation of heme oxygenase 1-mediated anti-inflammatory effect[J]. Int Immunopharmacol, 2018, 54: 153-162.

[54] K. Nistala, L. R. Nistala, L. R. Wedderburn, Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis[J]. Rheumatology (Oxford), 2009, 48: 602-606.

[55] Heo YJ, Joo YB, Oh H J, et al. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4 + T cell population of rheumatoid arthritis patients[J]. Immunol Lett, 2010, 127: 150-156.

Funding

National Natural Science Foundation of China(82274329)

National Natural Science Foundation of China(82304991)

China Postdoctoral Science Foundation(2023M732336)

Shanghai Science and Technology Committee Sailing Program Foundation(23YF1442500)